(Q44456155)

3 December 2017

title

Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease (English)

1 reference

3 December 2017

0 references

5

1 reference

3 December 2017

1

Barbara Borroni

1 reference

3 December 2017

Carla Pettenati

2

1 reference

3 December 2017

Tania Bordonali

series ordinal

3

1 reference

3 December 2017

Nabil Akkawi

series ordinal

4

1 reference

3 December 2017

Alessandro Padovani

series ordinal

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

343

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

213-215

1 reference

High cholesterol affects platelet APP processing in controls and in AD patients

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900336-7

7 January 2021

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900336-7

7 January 2021

Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900336-7

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900336-7

7 January 2021

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900336-7

7 January 2021

Alzheimer's disease. Bad for the heart, bad for the mind?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900336-7

7 January 2021

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900336-7

7 January 2021

Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900336-7

7 January 2021

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900336-7

7 January 2021

10.1016/S0304-3940(03)00336-7

Identifiers

DOI

1 reference

3 December 2017

1 reference